array comparative genomic hybridization agilent Search Results


90
Agilent technologies microarray scanner
A global view of gene modulation in the PBMCs of vaccinated infants (Vac, n = 20), 28 days after the vaccine booster, compared to the placebo cohort (Pla, n = 10) was determined by <t>microarray</t> analysis. The genes were classified according to their function. A heat map representation (a) and principal component analysis (PCA) (b) generated using the significantly modulated genes from at least one comparison versus day 0 are shown. (a) The color scale shows the significantly modulated genes from up- (dark red) to down-regulated (dark blue) to the right of each image. The values are shown on a log 2 scale. (b) The Y value is the log 2 -fold-changes in gene expression of the vaccinated group vs. the placebo group. The up-regulated changes are above the baseline (Y = 0, the same with placebo group), and the down-regulated changes are below the baseline. The bars represent the maximum and minimum. The mean of the fold-changes in gene expression with a 95% CI is shown as the rectangle. The line in the rectangle represents the mean of these fold changes in gene expression. The number of genes that changed after immunization is shown beside the rectangles on the image.
Microarray Scanner, supplied by Agilent technologies, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/microarray scanner/product/Agilent technologies
Average 90 stars, based on 1 article reviews
microarray scanner - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

90
Agilent technologies microarray hybridization chamber
A global view of gene modulation in the PBMCs of vaccinated infants (Vac, n = 20), 28 days after the vaccine booster, compared to the placebo cohort (Pla, n = 10) was determined by <t>microarray</t> analysis. The genes were classified according to their function. A heat map representation (a) and principal component analysis (PCA) (b) generated using the significantly modulated genes from at least one comparison versus day 0 are shown. (a) The color scale shows the significantly modulated genes from up- (dark red) to down-regulated (dark blue) to the right of each image. The values are shown on a log 2 scale. (b) The Y value is the log 2 -fold-changes in gene expression of the vaccinated group vs. the placebo group. The up-regulated changes are above the baseline (Y = 0, the same with placebo group), and the down-regulated changes are below the baseline. The bars represent the maximum and minimum. The mean of the fold-changes in gene expression with a 95% CI is shown as the rectangle. The line in the rectangle represents the mean of these fold changes in gene expression. The number of genes that changed after immunization is shown beside the rectangles on the image.
Microarray Hybridization Chamber, supplied by Agilent technologies, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/microarray hybridization chamber/product/Agilent technologies
Average 90 stars, based on 1 article reviews
microarray hybridization chamber - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

90
Agilent technologies rna microarray scanner
A global view of gene modulation in the PBMCs of vaccinated infants (Vac, n = 20), 28 days after the vaccine booster, compared to the placebo cohort (Pla, n = 10) was determined by <t>microarray</t> analysis. The genes were classified according to their function. A heat map representation (a) and principal component analysis (PCA) (b) generated using the significantly modulated genes from at least one comparison versus day 0 are shown. (a) The color scale shows the significantly modulated genes from up- (dark red) to down-regulated (dark blue) to the right of each image. The values are shown on a log 2 scale. (b) The Y value is the log 2 -fold-changes in gene expression of the vaccinated group vs. the placebo group. The up-regulated changes are above the baseline (Y = 0, the same with placebo group), and the down-regulated changes are below the baseline. The bars represent the maximum and minimum. The mean of the fold-changes in gene expression with a 95% CI is shown as the rectangle. The line in the rectangle represents the mean of these fold changes in gene expression. The number of genes that changed after immunization is shown beside the rectangles on the image.
Rna Microarray Scanner, supplied by Agilent technologies, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/rna microarray scanner/product/Agilent technologies
Average 90 stars, based on 1 article reviews
rna microarray scanner - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

90
Agilent technologies hybridization chamber
A global view of gene modulation in the PBMCs of vaccinated infants (Vac, n = 20), 28 days after the vaccine booster, compared to the placebo cohort (Pla, n = 10) was determined by <t>microarray</t> analysis. The genes were classified according to their function. A heat map representation (a) and principal component analysis (PCA) (b) generated using the significantly modulated genes from at least one comparison versus day 0 are shown. (a) The color scale shows the significantly modulated genes from up- (dark red) to down-regulated (dark blue) to the right of each image. The values are shown on a log 2 scale. (b) The Y value is the log 2 -fold-changes in gene expression of the vaccinated group vs. the placebo group. The up-regulated changes are above the baseline (Y = 0, the same with placebo group), and the down-regulated changes are below the baseline. The bars represent the maximum and minimum. The mean of the fold-changes in gene expression with a 95% CI is shown as the rectangle. The line in the rectangle represents the mean of these fold changes in gene expression. The number of genes that changed after immunization is shown beside the rectangles on the image.
Hybridization Chamber, supplied by Agilent technologies, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/hybridization chamber/product/Agilent technologies
Average 90 stars, based on 1 article reviews
hybridization chamber - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

90
Agilent technologies hybridization oven
A global view of gene modulation in the PBMCs of vaccinated infants (Vac, n = 20), 28 days after the vaccine booster, compared to the placebo cohort (Pla, n = 10) was determined by <t>microarray</t> analysis. The genes were classified according to their function. A heat map representation (a) and principal component analysis (PCA) (b) generated using the significantly modulated genes from at least one comparison versus day 0 are shown. (a) The color scale shows the significantly modulated genes from up- (dark red) to down-regulated (dark blue) to the right of each image. The values are shown on a log 2 scale. (b) The Y value is the log 2 -fold-changes in gene expression of the vaccinated group vs. the placebo group. The up-regulated changes are above the baseline (Y = 0, the same with placebo group), and the down-regulated changes are below the baseline. The bars represent the maximum and minimum. The mean of the fold-changes in gene expression with a 95% CI is shown as the rectangle. The line in the rectangle represents the mean of these fold changes in gene expression. The number of genes that changed after immunization is shown beside the rectangles on the image.
Hybridization Oven, supplied by Agilent technologies, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/hybridization oven/product/Agilent technologies
Average 90 stars, based on 1 article reviews
hybridization oven - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

90
Agilent technologies 44 k array-based omparative genomic hybridization
A global view of gene modulation in the PBMCs of vaccinated infants (Vac, n = 20), 28 days after the vaccine booster, compared to the placebo cohort (Pla, n = 10) was determined by <t>microarray</t> analysis. The genes were classified according to their function. A heat map representation (a) and principal component analysis (PCA) (b) generated using the significantly modulated genes from at least one comparison versus day 0 are shown. (a) The color scale shows the significantly modulated genes from up- (dark red) to down-regulated (dark blue) to the right of each image. The values are shown on a log 2 scale. (b) The Y value is the log 2 -fold-changes in gene expression of the vaccinated group vs. the placebo group. The up-regulated changes are above the baseline (Y = 0, the same with placebo group), and the down-regulated changes are below the baseline. The bars represent the maximum and minimum. The mean of the fold-changes in gene expression with a 95% CI is shown as the rectangle. The line in the rectangle represents the mean of these fold changes in gene expression. The number of genes that changed after immunization is shown beside the rectangles on the image.
44 K Array Based Omparative Genomic Hybridization, supplied by Agilent technologies, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/44 k array-based omparative genomic hybridization/product/Agilent technologies
Average 90 stars, based on 1 article reviews
44 k array-based omparative genomic hybridization - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

90
Agilent technologies agilent-array
A global view of gene modulation in the PBMCs of vaccinated infants (Vac, n = 20), 28 days after the vaccine booster, compared to the placebo cohort (Pla, n = 10) was determined by <t>microarray</t> analysis. The genes were classified according to their function. A heat map representation (a) and principal component analysis (PCA) (b) generated using the significantly modulated genes from at least one comparison versus day 0 are shown. (a) The color scale shows the significantly modulated genes from up- (dark red) to down-regulated (dark blue) to the right of each image. The values are shown on a log 2 scale. (b) The Y value is the log 2 -fold-changes in gene expression of the vaccinated group vs. the placebo group. The up-regulated changes are above the baseline (Y = 0, the same with placebo group), and the down-regulated changes are below the baseline. The bars represent the maximum and minimum. The mean of the fold-changes in gene expression with a 95% CI is shown as the rectangle. The line in the rectangle represents the mean of these fold changes in gene expression. The number of genes that changed after immunization is shown beside the rectangles on the image.
Agilent Array, supplied by Agilent technologies, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/agilent-array/product/Agilent technologies
Average 90 stars, based on 1 article reviews
agilent-array - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

90
Agilent technologies microarray hybridization
Demographics of the patients and controls included in the <t> microarray </t> screening cohort.
Microarray Hybridization, supplied by Agilent technologies, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/microarray hybridization/product/Agilent technologies
Average 90 stars, based on 1 article reviews
microarray hybridization - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

90
Agilent technologies g2565aa microarray scanner
Demographics of the patients and controls included in the <t> microarray </t> screening cohort.
G2565aa Microarray Scanner, supplied by Agilent technologies, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/g2565aa microarray scanner/product/Agilent technologies
Average 90 stars, based on 1 article reviews
g2565aa microarray scanner - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

90
Agilent technologies surescan microarray scanner
Demographics of the patients and controls included in the <t> microarray </t> screening cohort.
Surescan Microarray Scanner, supplied by Agilent technologies, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/surescan microarray scanner/product/Agilent technologies
Average 90 stars, based on 1 article reviews
surescan microarray scanner - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

90
Agilent technologies oligonucleotide array comparative genomic hybridization
Demographics of the patients and controls included in the <t> microarray </t> screening cohort.
Oligonucleotide Array Comparative Genomic Hybridization, supplied by Agilent technologies, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/oligonucleotide array comparative genomic hybridization/product/Agilent technologies
Average 90 stars, based on 1 article reviews
oligonucleotide array comparative genomic hybridization - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

90
Agilent technologies human genome cgh microarrays
Demographics of the patients and controls included in the <t> microarray </t> screening cohort.
Human Genome Cgh Microarrays, supplied by Agilent technologies, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human genome cgh microarrays/product/Agilent technologies
Average 90 stars, based on 1 article reviews
human genome cgh microarrays - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

Image Search Results


A global view of gene modulation in the PBMCs of vaccinated infants (Vac, n = 20), 28 days after the vaccine booster, compared to the placebo cohort (Pla, n = 10) was determined by microarray analysis. The genes were classified according to their function. A heat map representation (a) and principal component analysis (PCA) (b) generated using the significantly modulated genes from at least one comparison versus day 0 are shown. (a) The color scale shows the significantly modulated genes from up- (dark red) to down-regulated (dark blue) to the right of each image. The values are shown on a log 2 scale. (b) The Y value is the log 2 -fold-changes in gene expression of the vaccinated group vs. the placebo group. The up-regulated changes are above the baseline (Y = 0, the same with placebo group), and the down-regulated changes are below the baseline. The bars represent the maximum and minimum. The mean of the fold-changes in gene expression with a 95% CI is shown as the rectangle. The line in the rectangle represents the mean of these fold changes in gene expression. The number of genes that changed after immunization is shown beside the rectangles on the image.

Journal: PLoS ONE

Article Title: Study of the Integrated Immune Response Induced by an Inactivated EV71 Vaccine

doi: 10.1371/journal.pone.0054451

Figure Lengend Snippet: A global view of gene modulation in the PBMCs of vaccinated infants (Vac, n = 20), 28 days after the vaccine booster, compared to the placebo cohort (Pla, n = 10) was determined by microarray analysis. The genes were classified according to their function. A heat map representation (a) and principal component analysis (PCA) (b) generated using the significantly modulated genes from at least one comparison versus day 0 are shown. (a) The color scale shows the significantly modulated genes from up- (dark red) to down-regulated (dark blue) to the right of each image. The values are shown on a log 2 scale. (b) The Y value is the log 2 -fold-changes in gene expression of the vaccinated group vs. the placebo group. The up-regulated changes are above the baseline (Y = 0, the same with placebo group), and the down-regulated changes are below the baseline. The bars represent the maximum and minimum. The mean of the fold-changes in gene expression with a 95% CI is shown as the rectangle. The line in the rectangle represents the mean of these fold changes in gene expression. The number of genes that changed after immunization is shown beside the rectangles on the image.

Article Snippet: After hybridization, the microarrays were scanned in the Agilent Microarray Scanner (Cat# G2565CA, Agilent, CA, USA), and the raw data were obtained by Feature Extraction Software 10.7 (Agilent, CA, USA) and normalized using the Quantile algorithm in Gene Spring 11.0 (Agilent, CA, USA).

Techniques: Microarray, Generated, Expressing

Measure of serum proinflammatory cytokines (a) and the modulation of the expression of genes associated with the inflammatory response (b). (a) Levels of serum proinflammatory cytokines in vaccinated and placebo subjects. All cytokine (IL-1b, IL-2, IL-4, IL-5, IL-6, IL-8, IL-10, IL12p70, TNF-α and IFN-γ) levels were measured with an R&D Systems assay kits according to the manufacturer protocol. (b) The genes modulated and associated with the inflammatory response in vaccinated group (Vac) and placebo group (Pla) were classified and fallen under different functional categories: (1) ILs group: IL1A, IL1B, IL2RA, NFKBIZ (activator of IL-6 expression), IL8, IL17C, IL26 and IL32 in the IL group; (2) TNFs group: TNFAIP2 and TNFAIP6; (3) IFNs group: IFNA10 and OAS2 (activator of IFN-γ); (4) chemokines group: CCL3, CCL4, CCL15, CCL23, CCL26, CXCL1, CXCL3 and CXCR7. The levels of gene expression were measured by microarray analysis as described in the Methods. Data are shown in log 2 scale.

Journal: PLoS ONE

Article Title: Study of the Integrated Immune Response Induced by an Inactivated EV71 Vaccine

doi: 10.1371/journal.pone.0054451

Figure Lengend Snippet: Measure of serum proinflammatory cytokines (a) and the modulation of the expression of genes associated with the inflammatory response (b). (a) Levels of serum proinflammatory cytokines in vaccinated and placebo subjects. All cytokine (IL-1b, IL-2, IL-4, IL-5, IL-6, IL-8, IL-10, IL12p70, TNF-α and IFN-γ) levels were measured with an R&D Systems assay kits according to the manufacturer protocol. (b) The genes modulated and associated with the inflammatory response in vaccinated group (Vac) and placebo group (Pla) were classified and fallen under different functional categories: (1) ILs group: IL1A, IL1B, IL2RA, NFKBIZ (activator of IL-6 expression), IL8, IL17C, IL26 and IL32 in the IL group; (2) TNFs group: TNFAIP2 and TNFAIP6; (3) IFNs group: IFNA10 and OAS2 (activator of IFN-γ); (4) chemokines group: CCL3, CCL4, CCL15, CCL23, CCL26, CXCL1, CXCL3 and CXCR7. The levels of gene expression were measured by microarray analysis as described in the Methods. Data are shown in log 2 scale.

Article Snippet: After hybridization, the microarrays were scanned in the Agilent Microarray Scanner (Cat# G2565CA, Agilent, CA, USA), and the raw data were obtained by Feature Extraction Software 10.7 (Agilent, CA, USA) and normalized using the Quantile algorithm in Gene Spring 11.0 (Agilent, CA, USA).

Techniques: Expressing, Functional Assay, Microarray

Demographics of the patients and controls included in the  microarray  screening cohort.

Journal: Data in Brief

Article Title: Circulating miRNome profiling data in Behçet's syndrome

doi: 10.1016/j.dib.2021.107435

Figure Lengend Snippet: Demographics of the patients and controls included in the microarray screening cohort.

Article Snippet: Description of data collection , Data obtained by performing miRNA Agilent Microarray hybridization experiments, followed by data extraction and analysis using available dedivcated scripts for data pre-processing and expression analysis. Expression data were compared between patients and healthy controls..

Techniques: Microarray

DE miRNAs identified by  microarray  analysis in the screening phase.

Journal: Data in Brief

Article Title: Circulating miRNome profiling data in Behçet's syndrome

doi: 10.1016/j.dib.2021.107435

Figure Lengend Snippet: DE miRNAs identified by microarray analysis in the screening phase.

Article Snippet: Description of data collection , Data obtained by performing miRNA Agilent Microarray hybridization experiments, followed by data extraction and analysis using available dedivcated scripts for data pre-processing and expression analysis. Expression data were compared between patients and healthy controls..

Techniques: Microarray, Sequencing

GEO  microarray  data description.

Journal: Data in Brief

Article Title: Circulating miRNome profiling data in Behçet's syndrome

doi: 10.1016/j.dib.2021.107435

Figure Lengend Snippet: GEO microarray data description.

Article Snippet: Description of data collection , Data obtained by performing miRNA Agilent Microarray hybridization experiments, followed by data extraction and analysis using available dedivcated scripts for data pre-processing and expression analysis. Expression data were compared between patients and healthy controls..

Techniques: Microarray

Journal: Data in Brief

Article Title: Circulating miRNome profiling data in Behçet's syndrome

doi: 10.1016/j.dib.2021.107435

Figure Lengend Snippet:

Article Snippet: Description of data collection , Data obtained by performing miRNA Agilent Microarray hybridization experiments, followed by data extraction and analysis using available dedivcated scripts for data pre-processing and expression analysis. Expression data were compared between patients and healthy controls..

Techniques: Microarray, Hybridization, Labeling, Expressing